Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 89
News
News | 31 March 2023

Lonza completes drug product manufacturing line in Visp

This expansion follows the groundbreaking of a large-scale commercial drug product facility in Stein (CH), in another milestone for Lonza’s Drug Product Services (DPS) offering

News
News | 31 March 2023

Evonik starts construction of US$220 million lipid innovation center in Lafayette

Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness

News
News | 31 March 2023

MMP Industries wins its first commercial order from Aurobindo Pharma

The order marks a significant milestone for MMP Industries that will contribute to the company's revenue in the coming financial year

News
News | 31 March 2023

Abberior installs STED Microscope at MBC BioLabs

Stedycon Sted super-resolution fluorescence microscope

News
News | 30 March 2023

MPP signs sublicences with Aurobindo, Cipla and Viatris to produce generic versions of HIV prevention medicine

Licences should enable potentially millions of people living in areas most impacted by HIV to access this innovative prevention medicine through low-cost generic manufacturers

News
News | 29 March 2023

Dr. Moopen’s Family increases 4% stake for Rs. 460 crore in Aster DM Healthcare

The increase of stake in Aster DM Healthcare is a reiteration of the confidence in the business across geographies

News
News | 29 March 2023

Thalassemics India celebrates 35 years of service in Thalassemia

The event witnessed a historic journey of Thalassemics India gracing the theme “LAKSH”

News
News | 28 March 2023

Thermo Fisher Scientific opens cell therapy facility at University of California

The San Francisco facility is part of Thermo Fisher’s global pharma services network of more than 15 locations supporting cell and gene therapies.

News
News | 25 March 2023

IIT Kanpur and University at Buffalo to enrich research in Biomedicine & Bioengineering

The agreement will facilitate the establishment of the IITK-UB Joint Center of Excellence in Biomedicine and Bioengineering

News
News | 25 March 2023

Pfizer acquisition of ADC trailblazer Seagen a worthy investment: GlobalData

Pfizer’s total cumulative revenue from Seagen therapies is expected to reach $36 billion by 2028, according to GlobalData, a leading data and analytics company.

News
News | 25 March 2023

Quantumzyme receives patent for development of green catalyst in India

The patent was granted for creating a green catalyst for one of the world's most significant chemical reactions

News
News | 23 March 2023

PM to address One World TB Summit tomorrow

PM to launch TB-Mukt Panchayat initiative; official pan-India rollout of a shorter TB Preventive Treatment and Family-centric care model for TB

News
News | 23 March 2023

Emmes acquires Essex Management

Essex enriches and complements Emmes’ services

News
News | 22 March 2023

PHARMAP 2023 to focus on pharmaceutical challenges and strategies

The Congress gathers the whole value chain of the pharmaceutical industry on June, 12-13, 2023 in Switzerland

News
News | 21 March 2023

Serum Institute of India likely front-runner to win supply of HPV vaccines for UIP, says GlobalData

The Indian government will float a global tender in April 2023 to procure HPV vaccines.

News
News | 20 March 2023

Janssen announces novel dengue antiviral demonstrates efficacy in pre-clinical data

The antiviral is efficacious in non-human primates, and is safe and well-tolerated in humans

News
News | 20 March 2023

Phase 3 data show Deuruxolitinib significantly improve scalp hair regrowth in Alopecia Areata

The Phase 3 data presented at AAD include a comprehensive review of the THRIVE-AA2 results and further elaborate the topline data reported in August 2022

News
News | 18 March 2023

Nutricircle introduces nutrition based plant Protein isolates

The objective of launching these products at AAHAR is to create awareness on the consumption of protein based products

News
News | 18 March 2023

Eiko LifeSciences to acquire 5% stake in Vivacious Pharmatex

ELL will be the preferred source of supply for some the key Raw Materials to VPPL at "Arm's Length" transaction.

Startup

Digitization